Investment Q&A

Q: Hello Team,
Although you do not cover US stocks, please give your recommendation on below healthcare stocks based on current valuation and future growth/dividend income potential for new money investments.
1) AMGN OR ABBV
2) GILD OR BIIB
3) PFE OR MRK
4) MDT OR ABT OR BDX
5) UNH or ANTM
6) ISRG OR SYK

Appreciate your great service.

Thanks
Ninad

Q: Follow up questions:
Thank you for your answer.
Are the expectations of 6 to 10 cents provided by the company or are you doing your own calculation to get this number ?
Also, as a business scale and grow, do you try to estimate future margin and profit (say 3 years out) or is it a futile exercise given that there are so many variables...
I am trying to get better at assessing companies like Reliq. I usually pass on them as they always seem too risky for me and 1-product company most times.
Any advise or general comment would help. Thank you
Pierre

Q: Can you please explain how you value this company in terms of ratios and financial metrics ?

Q: Vmd has been on quite a roll lately. Earnings were decent. Is there anything else to it? What are your thoughts on the company?

Q: could you give me your comment on NVCR

Q: Do you have an estimate of SIS earnings per share for say 2019 with their Swiss acquisition and any observations on issues associated with the integration of the new co; also is your price target of 21 based on the combined earnings and for which year?

Thanks

Q: What is the short interest on Reliq?

Q: I bought RHT at about 1.85 and didn't follow my own rule about limiting downside. With it sitting where it is now should it be kept or replaced? Could you name 3 growth oriented names (in portfolio or otherwise that you would rather hold if selling RHT?

Q: Thoughts on the RBC analyst posting an $11 target? Quite a drop on that. Would you buy on this dip? What price target would you put on the stock in a buyout scenario by a larger company? Is this likely?

Q: SIS has a surprised 5% pop today against a sea of red. Are you aware of any upcoming news? Usually (of course I'm just guessing here) that is a sign of a potential buyout, but I could be reading too much into this unusual one day move. Please enlighten me. Thanks.

Q: Hi, would you have any problems buying more cov to a full position at under $10, or would you wait for it to settle back a bit from it’s big move?
Thanks

Q: Hello 5I Team.
I'm intrigued with the heavy insider purchasing in Acerus Pharm, and, I like the business they are in. I took a very small position but would really appreciate your analysis prior to adding to ASP.
Thank you!
Brian

Q: Hello 5i!!!
Could I have your thoughts on Tandem Diabetes Care ?
Anything else in the sector you might prefer for a higher risk investor?
Thank you
Dave

Q: All things being neutral, what would your expectations be for Covalon's 2018 and 2019 earnings per share? Also, can you give a brief history of their cash levels (maybe for the previous 3 or 4 quarters?)

Secondly, I know you are not fans of averaging down. However, if you WERE to average down, would you take your initial purchase price in trying to determine your percentage weighting, or would you take the current market price? Example, lets say I take a 2% position in Covalon, which theoretically I would want to be my maximum weighting. Shortly afterwards the share price falls 50% (for the sake of easy math). Would I prohibit myself in buying more Covalon because my initial purchase price represented 2% of my portfolio or would I grant myself the option of averaging down because now my weighting in Covalon represents 1% of my portfolio, assuming my portfolio value remained the same.

Thanks and good luck to the staff's kids for their new school year.

John

Q: You say insiders have been buying reliq, where do you see that, i see no sigh of that. thanks

Q: Hi,
PLI has been moving up quickly the last couple of days...is there any news as to why it is moving up? Are you still predicting headwinds for this company?
Thanks

Q: Hi, I got in at a really good price and rode this to the $2.00 mark and sold most of my shares.
Do you think its a good investment at the current mid$1.40s or do you think it might go down a bit more? The charts seem to indicate its heading down.
Thanks !!

Q: Good morning Could you give me your thoughts on this company thanks Norm

Q: TH is om the move UP. What kind of upside do you see here.? What do insiders own ? RAK

Q: Further comment about press releases sent directly to investors from Covalon CEO Jeffrey Mandel: I own that stock. If memory serves, the stock hit a high of 9.15 on August 6 and then appears (in my naive understanding) to have become the victim of a short attack. Trading was halted and IIROC then asked the CEO what material change(s) -- if any -- might account for the abrupt drop -- which hit a low of 6.26 (nearly 40%). As an investor, I took Mandel's first direct emails (which began at that time) as reassurance to investors not to panic and dump the stock. COV has recovered somewhat since then, but I'm assuming that Mandel might be sensitive to the potential of another assault against his company (e.g., SHOP) and may want to inform investors directly of positive progress being made -- which include the last couple of messages that just arrived in my inbox.